These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3838399)

  • 61. [Molsidomine: importance in treatment of circulation disorders].
    Kmieć M; Ochmański W
    Przegl Lek; 1998; 55(10):532-6. PubMed ID: 10224868
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of molsidomine on left ventricular dimensions and cardiac function in patients with chronic heart failure.
    Berkenboom GM; Sobolski JC; Vandermoten PP; Stoupel EE; Degre SG
    Am Heart J; 1985 Mar; 109(3 Pt 2):691-3. PubMed ID: 3838405
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The metabolism of [14C]N-ethoxycarbonyl-3-morpholinosydnonimine (molsidomine) in man.
    Wilson ID; Fromson JM; Illing HP; Schraven E
    Xenobiotica; 1987 Jan; 17(1):93-104. PubMed ID: 3825179
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hemodynamic effects of molsidomine in patients with acute myocardial infarction.
    Reifart N; Neidl K; Kaltenbach M; Bussmann WD
    Am Heart J; 1985 Mar; 109(3 Pt 2):708-12. PubMed ID: 3919550
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Substituted sydnonimines: hemodynamic effects and distribution of coronary blood flow in normal and ischemic myocardium].
    Mosca SM; Gelpi RJ; Cingolani HE
    Acta Physiol Pharmacol Latinoam; 1985; 35(3):361-73. PubMed ID: 2938418
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Redistribution of the coronary blood flow, functional improvement of the ischemic myocardium and reduction of the size of an experimental infarction by molsidomine].
    Berdeaux A; Giudicelli JF
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):511-5. PubMed ID: 6364947
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical pharmacokinetics of prazosin.
    Jaillon P
    Clin Pharmacokinet; 1980; 5(4):365-76. PubMed ID: 6994981
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiovascular pharmacology of molsidomine.
    Thulesius O
    Bibl Cardiol; 1984; (38):234-43. PubMed ID: 6398071
    [No Abstract]   [Full Text] [Related]  

  • 69. Hemodynamic and coronary effects of molsidomine at basal state, during atrial pacing, and during cold pressor test in patients with stable angina pectoris.
    Juliard JM; Neukirch F; Zygelman M; Merillon JP; Michel PL; Pansard Y; Dahan M; Gourgon R
    Am Heart J; 1985 Mar; 109(3 Pt 2):662-6. PubMed ID: 3838404
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
    Beloev I; Tomov I; Elenkova A; Terzieva L
    Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Influence of aspirin on the hemodynamic effects of molsidomine in healthy volunteers].
    Weber S; de Lauture D; Puechavy C; Pipeau C; Chazelle F; Degeorges M
    Therapie; 1986; 41(3):153-7. PubMed ID: 3529482
    [No Abstract]   [Full Text] [Related]  

  • 72. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The influence of molsidomine on the hemodynamics of patients with chronic heart failure at rest and during exercise.
    Larbig DT; Milstrey HR; Nasse H; Kahle T
    Am Heart J; 1985 Mar; 109(3 Pt 2):688-90. PubMed ID: 3883738
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
    Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
    Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction.
    Cantelli I; Lolli C; Brunelli A; Bracchetti D
    Am Heart J; 1985 Mar; 109(3 Pt 2):716-9. PubMed ID: 3838410
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
    König FK; Grewe R; Wörz K
    Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
    [No Abstract]   [Full Text] [Related]  

  • 77. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R; Bethke TD; van Marle SP; Zech K
    Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Proceedings of the International Symposium on Molsidomine. November 5, 1983, Brussels, Belgium.
    Am Heart J; 1985 Mar; 109(3 Pt 2):625-724. PubMed ID: 3838397
    [No Abstract]   [Full Text] [Related]  

  • 79. [Effect of molsidomine on cardiac function in experimental transitory coronary insufficiency].
    Litvitskiĭ PF; Ol'binskaia LI; Sandrikov VA; Aksiuk MA
    Kardiologiia; 1981 Apr; 21(4):71-4. PubMed ID: 6894773
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacokinetics and bioavailability of pinacidil capsules in human volunteers.
    Laher MS; Hickey MP
    J Int Med Res; 1985; 13(3):159-62. PubMed ID: 4007251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.